• Article

P4-086 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease

Engelborghs, S., Holmes, C., McCulley, M. and De Deyn, P.P. 2004. P4-086 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease. Neurobiology of Aging. 25 (Suppl.2), pp. s498-s499.

TitleP4-086 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease
AuthorsEngelborghs, S., Holmes, C., McCulley, M. and De Deyn, P.P.
JournalNeurobiology of Aging
Journal citation25 (Suppl.2), pp. s498-s499
ISSN0197-4580
Year2004
Web address (URL)http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T09-4DPKJJT-22P-1&_cdi=4857&_user=121712&_orig=browse&_coverDate=07%2F31%2F2004&_sk=999749999.8997&view=c&wchp=dGLbVzb-zSkzk&md5=b76818774ba490cce0726b376fe9a2a6&ie=/sdarticle.pdf
Publication dates
Published2004

Related outputs

Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease
McCulley, M., Day, I. and Holmes, C. 2004. Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics. 124B (1), pp. 50-53. https://doi.org/10.1002/ajmg.b.20086

Permalink - https://westminsterresearch.westminster.ac.uk/item/93251/p4-086-5-ht2a-receptor-polymorphism-may-modulate-antipsychotic-treatment-response-in-alzheimer-s-disease


Share this

Tweet
Email

Usage statistics

77 total views
0 total downloads
These values cover views and downloads from WestminsterResearch and are for the period from September 2nd 2018, when this repository was created.